共 213 条
[1]
Oudemans-van Straaten HM(2011)Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate? Crit Care 15 202-127
[2]
Kellum JA(2016)Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials Crit Care 20 144-752
[3]
Bellomo R(1997)Impairment of citrate metabolism in acute hepatic failure Wien Klin Wochenschr 109 123-2455
[4]
Liu C(2001)Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation Crit Care Med 29 748-138
[5]
Mao Z(2003)Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients Crit Care Med 31 2450-1100
[6]
Kang H(2012)Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guidelines for acute kidney injury Kidney Int Suppl 2 1-560
[7]
Hu J(2012)Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients Crit Care 16 R97-251
[8]
Zhou F(2012)Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study Crit Care 16 R162-676
[9]
Apsner R(2015)Sustained low-efficiency dialysis with regional citrate anticoagulation in medical intensive care unit patients with liver failure: a prospective study J Crit Care 30 1096-15
[10]
Schwarzenhofer M(2015)Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study Crit Care 19 349-3029